Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Weimar

Showing results (141-150 of 436) with videos related to

Pageof 44
Sort By:
Blood Purification|February 26, 2003
Patients on chronic hemodialysis have no intrinsic lymphocyte defect upon stimulation with interleukin-2, interleukin-15 or tumor necrosis factor-alphaI C van Riemsdijk, C C Baan, E H M Loonen, et al.
Vaccine|March 1, 1987
Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine componentsW E Beyer, D J Versluis, P Kramer, et al.
Transplantation Proceedings|February 1, 1990
Passive immunization to prevent cytomegalovirus disease after kidney and heart transplantationW Weimar, H J Metselaar, A H Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 18, 1999
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipientJ J de Jong, T van Gelder, J N IJzermans, et al.
Renal Failure|November 1, 1995
Use of APACHE II classification to evaluate outcome and response to therapy in acute renal failure patients in a surgical intensive care unitE F van Bommel, N D Bouvy, W C Hop, et al.
Infection|July 1, 1987
Rapid demonstration of cytomegalovirus in clinical specimensP H Rothbarth, R J Diepersloot, H J Metselaar, et al.
Transplantation Proceedings|April 26, 2005
Nonresident living kidney donorsW Zuidema, N Tronchet, A Luchtenburg, et al.
American Journal of Nephrology|January 1, 1994
Time course of the decline in renal function in cyclosporine-treated heart transplant recipientsR Zietse, A H Balk, M A vd Dorpel, et al.
Transplantation Proceedings|February 1, 1989
Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safetyH J Metselaar, J Velzing, P H Rothbarth, et al.
Blood Pressure. Supplement|January 1, 1994
Effect of isradipine on cyclosporin A-related hypertensionM A van den Dorpel, R Zietse, J N Ijzermans, et al.
Pageof 44

Showing results (141-150 of 436) with videos related to

Sort By:
Pageof 44
Blood Purification|February 26, 2003
Patients on chronic hemodialysis have no intrinsic lymphocyte defect upon stimulation with interleukin-2, interleukin-15 or tumor necrosis factor-alphaI C van Riemsdijk, C C Baan, E H M Loonen, et al.
Vaccine|March 1, 1987
Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine componentsW E Beyer, D J Versluis, P Kramer, et al.
Transplantation Proceedings|February 1, 1990
Passive immunization to prevent cytomegalovirus disease after kidney and heart transplantationW Weimar, H J Metselaar, A H Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 18, 1999
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipientJ J de Jong, T van Gelder, J N IJzermans, et al.
Renal Failure|November 1, 1995
Use of APACHE II classification to evaluate outcome and response to therapy in acute renal failure patients in a surgical intensive care unitE F van Bommel, N D Bouvy, W C Hop, et al.
Infection|July 1, 1987
Rapid demonstration of cytomegalovirus in clinical specimensP H Rothbarth, R J Diepersloot, H J Metselaar, et al.
Transplantation Proceedings|April 26, 2005
Nonresident living kidney donorsW Zuidema, N Tronchet, A Luchtenburg, et al.
American Journal of Nephrology|January 1, 1994
Time course of the decline in renal function in cyclosporine-treated heart transplant recipientsR Zietse, A H Balk, M A vd Dorpel, et al.
Transplantation Proceedings|February 1, 1989
Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safetyH J Metselaar, J Velzing, P H Rothbarth, et al.
Blood Pressure. Supplement|January 1, 1994
Effect of isradipine on cyclosporin A-related hypertensionM A van den Dorpel, R Zietse, J N Ijzermans, et al.
Pageof 44